Araris Biotech AG Announces Research Collaboration with Taiho Pharmaceutical

SparingVision named a ‘Fierce 15’ Company by Fierce Biotech

4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing

4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A

4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics

Araris Biotech Closes $24 Million Financing Round